nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—CYP1A2—chronic obstructive pulmonary disease	0.575	1	CbGaD
Niclosamide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0741	0.27	CbGbCtD
Niclosamide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0741	0.27	CbGbCtD
Niclosamide—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.07	0.255	CbGbCtD
Niclosamide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0562	0.205	CbGbCtD
Niclosamide—STAT3—respiratory system—chronic obstructive pulmonary disease	0.00569	0.195	CbGeAlD
Niclosamide—STAT3—connective tissue—chronic obstructive pulmonary disease	0.00501	0.171	CbGeAlD
Niclosamide—STAT3—bronchus—chronic obstructive pulmonary disease	0.00468	0.16	CbGeAlD
Niclosamide—STAT3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00458	0.157	CbGeAlD
Niclosamide—STAT3—trachea—chronic obstructive pulmonary disease	0.0042	0.144	CbGeAlD
Niclosamide—STAT3—lung—chronic obstructive pulmonary disease	0.00302	0.103	CbGeAlD
Niclosamide—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00134	0.046	CbGeAlD
Niclosamide—STAT3—IL27-mediated signaling events—IL1B—chronic obstructive pulmonary disease	0.00093	0.00768	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—CRP—chronic obstructive pulmonary disease	0.000929	0.00767	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—CD8A—chronic obstructive pulmonary disease	0.000898	0.00742	CbGpPWpGaD
Niclosamide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00088	0.00726	CbGpPWpGaD
Niclosamide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000877	0.00724	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by PTP1B—LEP—chronic obstructive pulmonary disease	0.000838	0.00692	CbGpPWpGaD
Niclosamide—STAT3—FGF signaling pathway—PLAU—chronic obstructive pulmonary disease	0.000825	0.00681	CbGpPWpGaD
Niclosamide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000798	0.00659	CbGpPWpGaD
Niclosamide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000749	0.00619	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—MMP1—chronic obstructive pulmonary disease	0.000725	0.00598	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—TGFB1—chronic obstructive pulmonary disease	0.000723	0.00597	CbGpPWpGaD
Niclosamide—CYP1A2—lung—chronic obstructive pulmonary disease	0.000714	0.0244	CbGeAlD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—EDN1—chronic obstructive pulmonary disease	0.000702	0.0058	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—IL1B—chronic obstructive pulmonary disease	0.000701	0.00579	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—NOS2—chronic obstructive pulmonary disease	0.000697	0.00575	CbGpPWpGaD
Niclosamide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000682	0.00563	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—TNF—chronic obstructive pulmonary disease	0.000675	0.00557	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.000661	0.00546	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000648	0.00535	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—NOS2—chronic obstructive pulmonary disease	0.000645	0.00533	CbGpPWpGaD
Niclosamide—STAT3—IL12 signaling mediated by STAT4—TGFB1—chronic obstructive pulmonary disease	0.000645	0.00532	CbGpPWpGaD
Niclosamide—STAT3—Dopaminergic Neurogenesis—TGFB1—chronic obstructive pulmonary disease	0.000645	0.00532	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—SERPINE1—chronic obstructive pulmonary disease	0.000638	0.00527	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—NOS2—chronic obstructive pulmonary disease	0.000638	0.00527	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—LEP—chronic obstructive pulmonary disease	0.000625	0.00516	CbGpPWpGaD
Niclosamide—STAT3—IFN-gamma pathway—IL1B—chronic obstructive pulmonary disease	0.000622	0.00514	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	0.000604	0.00499	CbGpPWpGaD
Niclosamide—STAT3—IL-3 Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	0.000584	0.00482	CbGpPWpGaD
Niclosamide—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00058	0.00479	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—KL—chronic obstructive pulmonary disease	0.000563	0.00465	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by TCPTP—VEGFA—chronic obstructive pulmonary disease	0.000558	0.00461	CbGpPWpGaD
Niclosamide—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000558	0.00461	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—SERPINE1—chronic obstructive pulmonary disease	0.00055	0.00454	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Leptin—IL6—chronic obstructive pulmonary disease	0.000545	0.0045	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—IL6—chronic obstructive pulmonary disease	0.000545	0.0045	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—NOS3—chronic obstructive pulmonary disease	0.000519	0.00428	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—TNF—chronic obstructive pulmonary disease	0.000509	0.0042	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000508	0.0042	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—KL—chronic obstructive pulmonary disease	0.000506	0.00418	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by TCPTP—EGFR—chronic obstructive pulmonary disease	0.000502	0.00415	CbGpPWpGaD
Niclosamide—STAT3—FGF signaling pathway—MMP9—chronic obstructive pulmonary disease	0.000489	0.00404	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—IL1B—chronic obstructive pulmonary disease	0.000476	0.00393	CbGpPWpGaD
Niclosamide—STAT3—Interleukin-11 Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000475	0.00392	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—KL—chronic obstructive pulmonary disease	0.000469	0.00387	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	0.000468	0.00387	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—KL—chronic obstructive pulmonary disease	0.000459	0.00379	CbGpPWpGaD
Niclosamide—STAT3—IL-3 Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000435	0.0036	CbGpPWpGaD
Niclosamide—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00043	0.00355	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—ERBB3—chronic obstructive pulmonary disease	0.000422	0.00348	CbGpPWpGaD
Niclosamide—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000421	0.00348	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	0.000416	0.00344	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—KL—chronic obstructive pulmonary disease	0.000415	0.00343	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000413	0.00341	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—IL6—chronic obstructive pulmonary disease	0.000411	0.00339	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by PTP1B—EGFR—chronic obstructive pulmonary disease	0.000407	0.00336	CbGpPWpGaD
Niclosamide—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000405	0.00335	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—TGFB1—chronic obstructive pulmonary disease	0.000403	0.00333	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000403	0.00333	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000399	0.00329	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000392	0.00323	CbGpPWpGaD
Niclosamide—Diflunisal—ALB—chronic obstructive pulmonary disease	0.000386	0.658	CrCbGaD
Niclosamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000379	0.00313	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—ERBB3—chronic obstructive pulmonary disease	0.000379	0.00313	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—VEGFA—chronic obstructive pulmonary disease	0.000378	0.00312	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—TNF—chronic obstructive pulmonary disease	0.000376	0.00311	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—IL6—chronic obstructive pulmonary disease	0.000364	0.00301	CbGpPWpGaD
Niclosamide—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00036	0.00297	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—ERBB3—chronic obstructive pulmonary disease	0.000352	0.0029	CbGpPWpGaD
Niclosamide—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000346	0.00286	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—ERBB3—chronic obstructive pulmonary disease	0.000344	0.00284	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—HDAC2—chronic obstructive pulmonary disease	0.000344	0.00284	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—MMP9—chronic obstructive pulmonary disease	0.000343	0.00283	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000339	0.0028	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—IL6—chronic obstructive pulmonary disease	0.000339	0.0028	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	0.000336	0.00278	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—EGFR—chronic obstructive pulmonary disease	0.000332	0.00274	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—KL—chronic obstructive pulmonary disease	0.000319	0.00264	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—chronic obstructive pulmonary disease	0.000317	0.00262	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000316	0.00261	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—ERBB3—chronic obstructive pulmonary disease	0.000311	0.00257	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—TNF—chronic obstructive pulmonary disease	0.000306	0.00252	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000303	0.0025	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.000302	0.0025	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL1B—chronic obstructive pulmonary disease	0.000298	0.00246	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—TP53—chronic obstructive pulmonary disease	0.000286	0.00236	CbGpPWpGaD
Niclosamide—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000285	0.00236	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—chronic obstructive pulmonary disease	0.000283	0.00234	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—TP53—chronic obstructive pulmonary disease	0.000279	0.0023	CbGpPWpGaD
Niclosamide—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000279	0.0023	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000273	0.00225	CbGpPWpGaD
Niclosamide—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000267	0.00221	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	0.000265	0.00219	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—TNF—chronic obstructive pulmonary disease	0.000264	0.00218	CbGpPWpGaD
Niclosamide—STAT3—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000256	0.00211	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—NOS3—chronic obstructive pulmonary disease	0.000253	0.00209	CbGpPWpGaD
Niclosamide—STAT3—Immune System—LY96—chronic obstructive pulmonary disease	0.000249	0.00205	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000246	0.00203	CbGpPWpGaD
Niclosamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000241	0.00199	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	0.000239	0.00198	CbGpPWpGaD
Niclosamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000238	0.00196	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—EGFR—chronic obstructive pulmonary disease	0.000232	0.00192	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—MMP9—chronic obstructive pulmonary disease	0.000227	0.00187	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000223	0.00184	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00021	0.00174	CbGpPWpGaD
Niclosamide—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000202	0.00167	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CXCL8—chronic obstructive pulmonary disease	0.000201	0.00166	CbGpPWpGaD
Niclosamide—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000201	0.342	CrCbGaD
Niclosamide—STAT3—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000199	0.00165	CbGpPWpGaD
Niclosamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000195	0.00161	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000186	0.00154	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00153	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00153	CbGpPWpGaD
Niclosamide—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00153	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	0.000183	0.00151	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000182	0.00151	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00018	0.00149	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—IL6—chronic obstructive pulmonary disease	0.000178	0.00147	CbGpPWpGaD
Niclosamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.00144	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL6—chronic obstructive pulmonary disease	0.000174	0.00144	CbGpPWpGaD
Niclosamide—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.00143	CbGpPWpGaD
Niclosamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.00143	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000165	0.00136	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	0.000165	0.00136	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—EGFR—chronic obstructive pulmonary disease	0.000164	0.00135	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	0.000153	0.00126	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.000152	0.00125	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.00015	0.00124	CbGpPWpGaD
Niclosamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.00123	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	0.000149	0.00123	CbGpPWpGaD
Niclosamide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00122	CbGpPWpGaD
Niclosamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00117	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	0.000141	0.00116	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	0.000139	0.00115	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000138	0.00114	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	0.000135	0.00112	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	0.000127	0.00105	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000126	0.00104	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000125	0.00103	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000125	0.00103	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000123	0.00102	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	0.000123	0.00102	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—TP53—chronic obstructive pulmonary disease	0.000123	0.00102	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.001	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	0.000117	0.00097	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000116	0.000959	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	0.000115	0.000948	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TLR2—chronic obstructive pulmonary disease	0.000113	0.000932	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—IL6—chronic obstructive pulmonary disease	0.000113	0.000932	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000107	0.000881	CbGpPWpGaD
Niclosamide—STAT3—Immune System—KL—chronic obstructive pulmonary disease	0.000106	0.000876	CbGpPWpGaD
Niclosamide—STAT3—Disease—HDAC2—chronic obstructive pulmonary disease	0.000105	0.00087	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000105	0.00087	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	0.000104	0.00086	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	0.000104	0.000859	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.000856	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000102	0.000845	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.000845	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000101	0.000834	CbGpPWpGaD
Niclosamide—STAT3—Disease—KL—chronic obstructive pulmonary disease	9.8e-05	0.000809	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	9.32e-05	0.000769	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.77e-05	0.000724	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	8.66e-05	0.000715	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.65e-05	0.000714	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD8A—chronic obstructive pulmonary disease	8.56e-05	0.000706	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.53e-05	0.000704	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	8.53e-05	0.000704	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP9—chronic obstructive pulmonary disease	8.32e-05	0.000687	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	8.14e-05	0.000672	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—IL6—chronic obstructive pulmonary disease	8e-05	0.000661	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ERBB3—chronic obstructive pulmonary disease	7.96e-05	0.000657	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	7.95e-05	0.000657	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.95e-05	0.000656	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.84e-05	0.000647	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	7.8e-05	0.000644	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	7.8e-05	0.000644	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.53e-05	0.000622	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.5e-05	0.000619	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	7.47e-05	0.000617	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.43e-05	0.000614	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	7.42e-05	0.000613	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	7.42e-05	0.000613	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.39e-05	0.00061	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.38e-05	0.00061	CbGpPWpGaD
Niclosamide—STAT3—Disease—ERBB3—chronic obstructive pulmonary disease	7.35e-05	0.000607	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.29e-05	0.000602	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CRP—chronic obstructive pulmonary disease	7.27e-05	0.000601	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TLR4—chronic obstructive pulmonary disease	6.97e-05	0.000576	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.86e-05	0.000567	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.86e-05	0.000566	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.79e-05	0.000561	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—EGFR—chronic obstructive pulmonary disease	6.72e-05	0.000555	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.7e-05	0.000553	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.44e-05	0.000532	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—chronic obstructive pulmonary disease	6.4e-05	0.000529	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.35e-05	0.000524	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.33e-05	0.000523	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS2—chronic obstructive pulmonary disease	6.12e-05	0.000506	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	6.06e-05	0.000501	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.66e-05	0.000467	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	5.18e-05	0.000428	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—chronic obstructive pulmonary disease	5.17e-05	0.000427	CbGpPWpGaD
Niclosamide—STAT3—Disease—SERPINE1—chronic obstructive pulmonary disease	5.16e-05	0.000426	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.14e-05	0.000425	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.95e-05	0.000409	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS3—chronic obstructive pulmonary disease	4.92e-05	0.000407	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.6e-05	0.00038	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL1B—chronic obstructive pulmonary disease	4.54e-05	0.000375	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.32e-05	0.000357	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.02e-05	0.000332	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.98e-05	0.000329	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.91e-05	0.000323	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.69e-05	0.000305	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.63e-05	0.0003	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.61e-05	0.000298	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EGFR—chronic obstructive pulmonary disease	3.46e-05	0.000286	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.45e-05	0.000285	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.43e-05	0.000283	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	3.34e-05	0.000276	CbGpPWpGaD
Niclosamide—STAT3—Disease—TGFB1—chronic obstructive pulmonary disease	3.26e-05	0.000269	CbGpPWpGaD
Niclosamide—STAT3—Disease—EGFR—chronic obstructive pulmonary disease	3.19e-05	0.000264	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.1e-05	0.000256	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.06e-05	0.000253	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.89e-05	0.000239	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.77e-05	0.000228	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—chronic obstructive pulmonary disease	2.66e-05	0.000219	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.48e-05	0.000205	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.47e-05	0.000204	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—chronic obstructive pulmonary disease	2.45e-05	0.000203	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.28e-05	0.000188	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.24e-05	0.000185	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.13e-05	0.000176	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.11e-05	0.000174	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.97e-05	0.000162	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.92e-05	0.000159	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.88e-05	0.000155	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.82e-05	0.000151	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.8e-05	0.000149	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.77e-05	0.000146	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.72e-05	0.000142	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000139	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.64e-05	0.000136	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.48e-05	0.000122	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.46e-05	0.00012	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.36e-05	0.000112	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.000106	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.000104	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.000103	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	9.59e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	9.09e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.76e-06	7.23e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	8.38e-06	6.92e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	7.48e-06	6.18e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.16e-06	5.91e-05	CbGpPWpGaD
